Overview

Safety and Efficacy Study of Etanercept (EnbrelĀ®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Status:
Terminated
Trial end date:
2004-05-06
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to determine the efficacy of etanercept in pediatric patients with systemically active system onset juvenile rheumatoid arthritis (SOJRA).
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Collaborator:
Immunex Corporation
Treatments:
Etanercept